TABLE 4.
Performance of AST-GN69 and AST-NX06 cards compared to BMD for 11 S. maltophilia isolates
| Antimicrobiala | BPb | No. of isolatesc |
Performance (no. [%])d |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Total | R | I | S | EA | CA | VMEs | MEs | mEs | ||
| Levofloxacin | V2/C | 11 | 1 | 0 | 10 | 11 (100) | 10 (90.9) | 0 (0) | 0 (0) | 1 (9.1) |
| SXT | V2/C | 11 | 2 | 0 | 9 | 11 (100) | 11 (100) | 0 (0) | 0 (0) | 0 (0) |
a
SXT, trimethoprim-sulfamethoxazole.
b
BP, breakpoint used to interpret MIC results; V2/C, Vitek 2 and CLSI M100S 26th edition breakpoints are the same.
c
R, resistant; I, intermediate; S, susceptible.
d
EA, essential agreement (MIC ±1 doubling dilution); CA, categorical agreement; VMEs, very major errors; MEs, major errors; mEs, minor errors.